Mesoblast (MEOBF) EBT Margin Growth (1y) (2015 - 2023)
Powered by 
Analysis
Mesoblast (MEOBF) EBT Margin Growth (1y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 672.00 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.23 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 13,390.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 6,324.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -64,750.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -2.31 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 314,854.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -2,558.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 371.00 |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -922,281.00 |
| Mar 31, 2023 | 9,988.00 |
| Dec 31, 2022 | -41,475.00 |
| Sep 30, 2022 | -49,521.00 |
| Jun 30, 2022 | -100,308.00 |
| Mar 31, 2022 | 32,820.00 |
| Dec 31, 2021 | 40,715.00 |
| Sep 30, 2021 | 130,490.00 |
| Mar 31, 2021 | -122,602.00 |
| Dec 31, 2020 | -19,387.00 |
| Sep 30, 2020 | -189,320.00 |
| Mar 31, 2020 | 201,205.00 |
| Dec 31, 2019 | 51,965.00 |
| Sep 30, 2019 | 13,016.00 |
| Jun 30, 2019 | 7,039.00 |
| Mar 31, 2019 | 11,987.00 |
| Dec 31, 2018 | -139,698.00 |
| Sep 30, 2018 | 67,131.00 |
| Jun 30, 2018 | 423,703.00 |
| Mar 31, 2018 | -86,642.00 |